Suppression of Collagen Induced Arthritis by Oral Administration of Type II Collagen: Changes in Immune and Arthritic Responses Mediated by Active Peripheral Suppression

References

• Stuart J. M., Townes A. S., Kang A. H. Collagen autoimmune arthritis. Ann Rev Immunol 1984; 2: 199–218
   PubMed Web of Science ®Google Scholar
• Stuart J. M., Watson W. C., Kang A. H. Collagen autoimmunity and arthritis. FASEB J 1988; 2: 2950–2956
   PubMed Web of Science ®Google Scholar
• Seki N., Sudo Y., Yoshioka T., Sugihara S., Fujitsu T., Sakuma S., Ogawa T., Hamaoka T., Senoh H., Fujiwara H. Type II collagen-induced arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol 1988; 140: 1477–1484
   PubMed Web of Science ®Google Scholar
• Thompson H. S. G., Staines N. A. Could specific oral tolerance be a therapy for autoimmune disease?. Immunology Today 1990; 11: 396–399
   PubMedGoogle Scholar
• Thompson H. S. G., Staines N. A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986; 64: 581–586
   PubMed Web of Science ®Google Scholar
• Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986; 83: 7443–7446
   PubMed Web of Science ®Google Scholar
• Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol 1988; 140: 440–445
   PubMed Web of Science ®Google Scholar
• Bitar D. M., Whitacre C. C. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell Immunol 1988; 112: 364–370
   PubMed Web of Science ®Google Scholar
• Nussenblatt R. B., Cäspi R. R., Mahdi R., Chan C. -C., Roberge F., Lider O., Weiner H. L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol 1990; 144: 1689–1695
   PubMed Web of Science ®Google Scholar
• Zhang Z. J., Lee C., Lider O., Weiner H. L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol 1990; 145: 2489–2493
   PubMed Web of Science ®Google Scholar
• Brod S. A., El-Sabbagh A., Sobel R. A., Hafler D. A., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: I.V. Suppression of chronic relapsing disease in the Lewis rat and Strain 13 guinea pig. Ann Neurol 1991; 29: 615–622
   PubMed Web of Science ®Google Scholar
• Zhang Z. J., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88: 1052–1056
   Web of Science ®Google Scholar
• Thompson S. J., Thompson H. S. G., Harper N., Day M., Coad A. J., Elson C. J., Staines N. A. Prevention of Pristane-induced arthritis by the oral administration of type II collagen. Immunology, 79: 152–157
   PubMed Web of Science ®Google Scholar
• Lee-Own V., Anderson J. C. Interaction between proteoglycan subunit and type II collagen from bovine nasal cartilage, and the preferential binding of proteoglycan subunit to type I collagen. Biochem J 1976; 153: 259–264
   PubMed Web of Science ®Google Scholar
• Duance V. C., Wotton S. F., Voyle C. A., Bailey A. J. Isolation and characterization of the precursor type M collagen. Biochem J 1984; 221: 885–889
   PubMed Web of Science ®Google Scholar
• Wood F. D., Pearson C. M., Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy 1969; 35: 456–467
   Web of Science ®Google Scholar
• Staines N. A., Hardingham T. E., Smith M., Henderson B. Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology 1981; 44: 737–744
   PubMed Web of Science ®Google Scholar
• Devey M. E., Bleasdale K., Lee S., Rath S. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase methods. J Immunol Methods 1988; 106: 119–125
   PubMed Web of Science ®Google Scholar
• Rath S., Stanley C. M., Steward M. W. An inhibition enzyme assay for estimating relative antibody affinity and affinity heterogeneity. J. Immunol Methods 1988; 106: 245–249
   PubMed Web of Science ®Google Scholar
• Staines N. A., Ekong T. A. N., Thompson H. S. G., Isaacs A. B., Loryman B., Major P., Hobbs S., Devey M. E. Low affinity antibodies against collagen type II are associated with pathology in collagen arthritis. J. Autoimmunity 1990; 3: 643–657
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Bevan D. J., Chisholm P. M. Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells. Immunology 1986; 59: 621–625
   PubMed Web of Science ®Google Scholar
• Julius M. F., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur J Immunol 1973; 3: 645–649
   PubMed Web of Science ®Google Scholar
• Siegel S. Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York 1956
   Google Scholar
• Thompson H. S. G., Staines N. A. Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagen. Agents and Actions 1986; 19: 318–319
   PubMedGoogle Scholar
• Thompson H. S. G., Henderson B., Spencer J. M., Hobbs S. M., Peppard J. V., Staines N. A. Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Clin Exp Immunol 1988; 72: 20–25
   PubMed Web of Science ®Google Scholar
• Thompson H. S. G., Harper N., Assaduliahi T., Hider R. C., Staines N. A. Prevention of collagen-induced arthritis by the oral administration of encapsulated type II collagen. Advances in Mucosal Immunology. Lancaster, Kluwer Academic Publ. 1990: 268–271, T. T. MacDonald, S. J. Challacombe, P. W. Bland, C. R. Stokes, R. V. Heatley, A. McI. Mowat
   Google Scholar
• Kresina T. F., Finegan C. K. Restricted expression of anti-type II collagen antibody isotypes in mice suppressed for collagen-induced arthritis. Ann Rheum Dis 1986; 45: 60–66
   PubMed Web of Science ®Google Scholar
• Thurau S. R., Chan C. C., Suh E., Nussenblatt R. B. Induction of oral tolerance to S-Antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J. Autoimmunity 1991; 4: 507–516
   PubMed Web of Science ®Google Scholar
• Singh V. K., Kalra H. K., Yamaki K., Shinohara T. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell Immunol 1992; 139: 81–90
   PubMed Web of Science ®Google Scholar
• Rahman J., Staines N. A. Contribution of the spleen, lymph nodes and bone marrow to the antibody response to collagen type II in collagen arthritis. Clin Exp Immunol 1991; 85: 48–54
   PubMed Web of Science ®Google Scholar
• Lider O., Santos L. M. B., Lee C. S. Y., Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein I.I. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 1989; 142: 748–752
   PubMed Web of Science ®Google Scholar
• Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor B after antigen specific triggering. Proc Natl Acad Sci USA 1992; 89: 421–425
   PubMed Web of Science ®Google Scholar
• Miller A., Lider O., Weiner H. L. Antigen-driven bystander suppression after the oral administration of antigens. J Exp Med 1991; 174: 791–798
   PubMed Web of Science ®Google Scholar
• Vrabec T. R., Gregerson D. S., Dua H. S., Donoso L. A. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity 1992; 121: 175–184
   Google Scholar
• Parish C. R., McKenzie I. F.C. A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J. Immunol Methods 1978; 20: 173–183
   PubMed Web of Science ®Google Scholar
• Mowat AMcI. The regulation of immune responses to dietary protein antigens. Immunol Today 1987; 8: 93–98
   PubMedGoogle Scholar
• Whitacre C. C., Geinapp I. E., Orosz C. G., Bitar D. M. Oral tolerance in experimental autoimmune encephalomyelitis. I.I.I. Evidence for clonal anergy. J. Immunol 1991; 147: 2155–2163
   PubMed Web of Science ®Google Scholar
• Asherson G. L., Zembala M., Perera M. A. A. C., Mayhew B., Thomas W. R. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in Peyer's patch, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 1977; 33: 145–151
   PubMed Web of Science ®Google Scholar
• Kagnoff M. E. Effects of antigen feeding on intestinal and systemic immune responses. I.I.I. Antigen-specific serum mediated suppression of homoral antibody responses after antigen feeding. Cell Immunol 1978; 40: 186–203
   PubMed Web of Science ®Google Scholar
• Bhogal B. S., Karkhanis Y. D., Bell M. K., Sanchez P., Zemick B., Siskind G. W., Thorbecke G. J. Production of auto-anti-idiotypic antibody during the normal immune response. X.I.I. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B cell tolerance in rabbits after antigen feeding. Cell Immunol 1986; 101: 93–104
   PubMed Web of Science ®Google Scholar
• Andre C., Heremans J. F., Vaerman J. P., Cambiaso C. L. A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med 1975; 142: 1509–1519
   PubMed Web of Science ®Google Scholar